These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2098972)

  • 1. [The reactivation of pulmonary tuberculosis after effective chemotherapy using rifampicin].
    Roslik SM; Pashkov IuN; Matveeva SL; Gerasimova TG; Liudvichek IA; Iushchenko LP; Iakovleva LM; Stepanenko AL; Pankova LI
    Vrach Delo; 1990 Nov; (11):18-20. PubMed ID: 2098972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current chemotherapy of pulmonary tuberculosis].
    Medici TC; Steiner A
    Schweiz Med Wochenschr; 1979 Feb; 109(6):190-9. PubMed ID: 424721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].
    Tamura M; Takazawa N; Asada T; Ikegaki H; Yamada M; Kushiro S; Tada T
    Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607
    [No Abstract]   [Full Text] [Related]  

  • 14. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
    Kobashi Y; Matsushima T
    Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Pogodaeva NP; Iavorskiĭ KM
    Probl Tuberk; 1994; (6):16-8. PubMed ID: 7708637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M; Tuchais E; Viallet S; Chauvet G
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)].
    Matsumiya T; Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R; Ishii A
    Kekkaku; 1980 Feb; 55(2):43-51. PubMed ID: 7373965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.